Scotia Capital Inc. Gsk PLC Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$42.05 - $47.77 $1.55 Million - $1.76 Million	-36,772 Reduced 35.4%	67,107 $2.92 Million
Q1 2022 May 09, 2022	BUY	$40.23 - $47.74 $134,327 - $159,403	3,339 Added 3.32%	103,879 $4.53 Million
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $5,832 - $6,796	-150 Reduced 0.15%	100,540 $4.43 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $37,509 - $41,735	967 Added 0.97%	100,690 $3.85 Million
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $758,337 - $860,916	20,765 Added 26.3%	99,723 $3.97 Million
Q1 2021 May 06, 2021	SELL	$34.27 - $40.01 $573,988 - $670,127	-16,749 Reduced 17.5%	78,958 $2.82 Million
Q4 2020 Feb 11, 2021	BUY	$34.07 - $39.94 $359,711 - $421,686	10,558 Added 12.4%	95,707 $3.52 Million
Q3 2020 Nov 12, 2020	BUY	$38.11 - $42.99 $1.01 Million - $1.14 Million	26,552 Added 45.31%	85,149 $3.21 Million
Q2 2020 Aug 11, 2020	BUY	$37.87 - $43.58 $345,222 - $397,275	9,116 Added 18.42%	58,597 $2.4 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $448,670 - $674,732	-13,818 Reduced 21.83%	49,481 $1.88 Million
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $6,762 - $7,768	161 Added 0.25%	63,299 $2.98 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $357,990 - $385,064	-8,848 Reduced 12.29%	63,138 $2.7 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $671,494 - $727,736	17,043 Added 31.02%	71,986 $2.88 Million
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $358,122 - $396,376	9,285 Added 20.34%	54,943 $2.3 Million
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $17,841 - $20,149	472 Added 1.04%	45,658 $1.74 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $536,227 - $575,888	-13,490 Reduced 22.99%	45,186 $1.82 Million
Q2 2018 Aug 13, 2018	BUY	$39.61 - $42.76 $10,971 - $11,844	277 Added 0.47%	58,676 $2.27 Million
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $253 - $281	-7 Reduced 0.01%	58,399 $2.28 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $1.44 Million - $1.71 Million	-40,809 Reduced 41.13%	58,406 $2.07 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $986,000 - $1.04 Million	25,000 Added 33.69%	99,215 $4.03 Million
Q2 2017 Aug 15, 2017	BUY	N/A	74,215	74,215 $3.2 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account